RecruitingNot ApplicableNCT05707078

PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

Sponsor

Rigshospitalet, Denmark

Enrollment

600 participants

Start Date

Mar 7, 2023

Study Type

INTERVENTIONAL

Conditions

Head and Neck Squamous Cell Carcinoma PET/CT

Summary

PET/CT follow up for Head and Neck Squamous Cell Carcinoma The following is a presentation of a prospective protocol, named PET/CT follow up for Head and Neck Squamous Cell Carcinoma (PET Follow), including patients who have completed radiotherapy treatment for squamous cell carcinoma of the head and neck (HNSCC). The purpose of this study is to investigate the diagnostic performance of 18F-fluorodeoxy-D-glucose (FDG) Positron Emission Tomography/ Computed Tomography (PET/CT) in patients with HNSCC after curative intended treatment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether PET/CT scans (a type of imaging that detects cancer activity) can improve the follow-up and detection of cancer recurrence in patients who completed curative treatment for head and neck squamous cell carcinoma (cancer of the mouth, throat, or voice box). **You may be eligible if...** - You are over 18 years old - You have completed curative treatment for head and neck squamous cell carcinoma (oral cavity, nasopharynx, oropharynx, hypopharynx, or larynx) - You are willing to give informed consent **You may NOT be eligible if...** - You refuse participation - Your neck lymph nodes were clinically negative before treatment (no nodal disease) - You had a neck dissection (lymph node removal surgery) before radiation - You are not eligible for surgery for any reason Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENeck dissection

Based on PET/CT scan patients will undergo neck dissection.

Locations(1)

Department of Otorhinolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05707078

Related Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT02734537676 locations

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT0500540346 locations

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT0711504313 locations

PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC

NCT062392202 locations

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

NCT0616353430 locations